{"schema_version":"secwatch.filing_event.v1","accession":"0001708599-25-000065","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.734698+00:00","generated_at":"2026-05-18T10:12:22.570762+00:00","sec_items":["5.08","8.01","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Serina Therapeutics sets 2025 annual meeting for Nov 7; updates proposal deadlines","bullets":["Annual meeting scheduled for November 7, 2025; location and time in proxy.","Rule 14a-8 stockholder proposals must be received by August 15, 2025.","Director nominations and other proposals due August 9, 2025; earliest July 10.","Meeting date change of >30 days from 2024 anniversary triggers adjusted deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001708599-25-000065","json":"https://secwatch.observer/filing/0001708599-25-000065.json","markdown":"https://secwatch.observer/filing/0001708599-25-000065.md","text":"https://secwatch.observer/filing/0001708599-25-000065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000065/0001708599-25-000065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000170859925000065/ser-20250701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:12:22.570762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}